Clinical Trials Browser

Phase EARLY_PHASE1 × Has results × Immunoglobulin G × Clear all

NCT02827838 2025-03-17

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Phase EARLY_PHASE1 Terminated

17 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT03132467 2024-06-05

Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer

Phase EARLY_PHASE1 Completed

16 enrolled 8 charts

Anatomic Stage II Breast Cancer AJCC v8